Dr Norman Marcus
Today, the evidence is converging: myofascial trigger points are not only real, they may be among the most common and underrecognized sources of persistent pain.
For decades, myofascial trigger points, those tender, tight knots within muscle fibers have been the subject of debate in clinical circles. In earlier years, some clinicians considered them minor contributors to pain, while others questioned their significance due to the absence of standardized diagnostic methods. But emerging research is challenging these assumptions, offering new clarity on the biological significance of trigger points and their central role in chronic pain.
A trigger point is a small, hyperirritable area within a taut band of skeletal muscle. Pressing on it often reproduces a patient’s familiar pain, sometimes locally, sometimes at a distance. This “referred pain” is one of the hallmark features of myofascial dysfunction.
Unlike nerve compression or joint arthritis, trigger points represent functional, not structural, disturbances. They involve:
These physiological changes make trigger points both painful and resistant to spontaneous resolution, especially when contributing factors: posture, stress, and overload persist.
For many years, skepticism persisted partly because conventional imaging technologies were unable to clearly identify trigger points within muscle tissue. Today, however, multiple research fields from molecular biology to ultrasound technology are providing compelling evidence.
Recent studies show that painful trigger points exhibit:
Trigger point regions contain elevated levels of:
These biochemical substances increase the sensitivity of local pain receptors, causing the muscle to react strongly to pressure and movement.
Electromyography (EMG) has revealed characteristic spontaneous electrical activity in trigger points. This activity is absent in normal muscle, reinforcing the idea that trigger points reflect a unique pathophysiological state.
Ultrasound Doppler studies show reduced perfusion and local ischemia around trigger points, conditions known to exacerbate pain.
Together, these findings support a clear biological model: trigger points are not subjective complaints; they are measurable, dysfunctional muscle sites with identifiable mechanisms.
Despite mounting evidence, trigger points remain under-evaluated in mainstream pain care. Several systemic factors contribute:
Many medical training programs devote limited time to the detailed evaluation of myofascial pain conditions. Clinicians receive extensive instruction in reading MRIs but little in palpation techniques that identify trigger points.
Because trigger points are difficult to detect through standard imaging methods, clinicians may rely heavily on structural findings when interpreting a patient’s symptoms.
Trigger point patterns can mimic nerve compression, joint arthritis, or visceral pain. Without proper training, these patterns are easily misattributed.
As a result, patients may experience delayed diagnosis and treatments that do not address the underlying muscular source of their pain.
When properly identified, trigger points respond well to targeted interventions:
Treatments that restore normal muscle function rather than simply suppress pain tend to yield durable results.
Research also suggests that treating trigger points effectively may decrease reliance on medications, repeated imaging, and invasive procedures.
As research continues to validate the biological underpinnings of myofascial trigger points, the field of pain medicine faces a critical opportunity. Integrating trigger point assessment into standard diagnostic workflows could transform outcomes for millions of patients living with unexplained pain.
Growing scientific evidence increasingly supports the view that trigger points represent genuine physiological dysfunction rather than purely subjective complaints. They are measurable dysfunctions with clear mechanistic pathways and they deserve a central role in chronic pain care.
Recognizing their importance is not just a step forward in research; it is a lifeline for patients whose pain has been misunderstood for far too long.
